1. Home
  2. News
  3. Proteomics International Laboratories Ltd.
  4. Partnership with QIMR Berghofer targets oesophageal cancer
More Proteomics International Laboratories Ltd. news
Proteomics International Laboratories Ltd.ASX: PIQ

Partnership with QIMR Berghofer targets oesophageal cancer

Oct 8, 2020 at 11:00 PM EDT · Issued by Proteomics International Laboratories Ltd.

Filed with ASX · Oct 8, 2020 at 11:00 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/partnership-with-qimr-berghofer-targets-oesophageal-cancer

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

  • June 2020 Quarterly Activities Report and Appendix 4CJul 28, 2020
  • PromarkerD Intellectual Property portfolio expandsJul 27, 2020
  • Appendix 3Y - Directors on-market purchase of sharesJun 28, 2020
  • Big pharma clinical study validates PromarkerD kidney testJun 14, 2020
  • Updated Investor PresentationJun 9, 2020

Later from Proteomics International Laboratories

  • First distribution agreement for PromarkerD immunoassayOct 15, 2020
  • Proteomics International raises $6m in successful PlacementOct 22, 2020
  • September 2020 Quarterly Activities Report and Appendix 4COct 27, 2020
  • Completion of Placement and Appendix 2ANov 1, 2020
  • Proteomics receives $1.1 million in R&D tax incentiveNov 2, 2020
All Proteomics International Laboratories news releases↗

Follow Proteomics International Laboratories into a list and get an email when it puts out news.

Follow Proteomics International Laboratories
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer